Pre-Market Earnings Report for July 29, 2025 : PG, UNH, AZN, MRK, BA, SPOT, AMT, RCL, ECL, UPS, PYPL, JCI

On July 29, 2025, a diverse group of companies, including Procter & Gamble, UnitedHealth Group, Merck, and Spotify, are scheduled to report Q2 2025 earnings. Consensus EPS forecasts show varied expectations, with Spotify projected for a 48.95% increase and UnitedHealth Group for a 28.82% decline, while Merck, despite an expected 11.84% decrease, has consistently beaten estimates. Additionally, P/E ratios for several firms like AstraZeneca, American Tower, Royal Caribbean, and Ecolab suggest higher earnings growth potential relative to their industry peers.

Analysis

The upcoming earnings reports on July 29, 2025, reveal a significant divergence in corporate performance across major sectors. A clear growth narrative is present for companies like Spotify (SPOT) and Royal Caribbean (RCL), which are projected to report substantial year-over-year EPS increases of 48.95% and 27.73%, respectively. This positive outlook is reinforced by RCL's consistent history of beating analyst expectations over the past four quarters. Conversely, several established firms face notable headwinds. UnitedHealth Group (UNH) is bracing for a significant 28.82% EPS decline, compounded by a recent earnings miss in the first quarter. Similarly, United Parcel Service (UPS) and Merck (MRK) are forecast to see EPS contract by 12.85% and 11.84%, respectively. However, Merck's perfect four-quarter streak of beating consensus estimates may provide a potential buffer against its negative forecast. In terms of valuation, several companies including AstraZeneca (AZN), American Tower (AMT), and Ecolab (ECL) trade at a considerable P/E premium to their industry peers, implying market expectations for superior growth that must be validated by their results. Boeing (BA) remains a special case, with a projected EPS of $-1.54, which, while still a loss, represents a 46.90% improvement from the prior year, signaling a potential, albeit slow, recovery.

Key Decisions for Investors

• Investors should monitor companies with strong projected EPS growth and a history of positive surprises, such as Royal Caribbean (RCL) and Spotify (SPOT), for potential upside momentum.
• For companies like Merck (MRK) and American Tower (AMT), which forecast an earnings decline but have consistently beaten estimates, the key will be whether another earnings beat is significant enough to overcome the negative year-over-year comparison.
• Caution is advised for UnitedHealth (UNH) and United Parcel Service (UPS), as their projections for double-digit EPS declines, coupled with recent earnings misses, signal heightened risk of underperformance.
• Scrutinize companies trading at a high P/E premium to their industry, like Ecolab (ECL) and Johnson Controls (JCI), as they face higher pressure to deliver strong results and guidance to justify their current valuations.
• Consider Boeing's (BA) report a critical check on its turnaround progress; while still loss-making, any positive deviation from the forecasted $-1.54 EPS could be interpreted as a bullish signal for its recovery trajectory.